JP
Jason Paul Steik sold $8K of PNTG stock
Jason Paul Steik, Chief Clinical Officer of Pennant Group, Inc. (PNTG), sold 218 shares of PNTG stock worth $8K, per an SEC Form 4 filed Nov 19, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 17, 2026, 2 days before it was made public.
PNTG has moved -6.6% since the trade date, from $36.50 to $34.09 (Nov 19, 2026 close).
- Traded
- Nov 17, 2026
- Disclosed
- Nov 19, 2026
- Filing delay
- 2 days
- Price since
- -6.6%
- Role
- Chief Clinical Officer
- Source
- SEC Form 4